CMS-10141 Alternate Second Notice Sent to Beneficiary Not Consider

Comprehensive Addiction and Recovery Act of 2016 (CARA) / Medicare Prescription Drug Benefit Program (CMS-10141)

Attachment 1d. Alternate 2nd Notice

Medicare Prescription Drug Benefit Program (Plans)

OMB: 0938-0964

Document [pdf]
Download: pdf | pdf
DEPARTMENT OF HEALTH AND HUMAN SERVICES
CENTERS FOR MEDICARE & MEDICAID SERVICES

[Part D Plan Logo]
YOUR ACCESS TO CERTAIN PART D DRUGS WILL NOT BE LIMITED
Date: [insert date]
Enrollee’s Name: [insert name]

Member Number: [insert member ID]

On [Insert date of initial notice], we sent you a notice that we planned to limit your access to
prescription [insert as appropriate: {opioids} or {benzodiazepines} or {opioids and benzodiazepines}]
through our drug management program.
After further review, we have decided that your access to these medications will NOT be limited under
the drug management program. There are no changes to the way these medications are covered for you
under our plan rules.
[Insert this section for Low Income Subsidy (LIS) beneficiaries:]
{As of the date of this notice, you’re eligible to use the quarterly Medicare Special Enrollment period
because you receive Extra Help with your prescription drug costs. You can also change plans during
other limited situations, such as if you move out of the plan’s service area or you lose or have a change
in your Extra Help. You can also change plans during the Annual Enrollment Period which occurs every
year from October 15 – December 7.}
If you have questions about this notice or our drug management program to help enrollees use
prescription opioid medications safely, contact us at:
[Plan Name] Toll Free: [Insert phone number]
TTY users: [Insert TTY]
[Insert call center hours of operation]
[Insert plan website]
[Insert plan mailing address]
[If the plan has a dedicated line (toll free), staff person, web portal, etc. for its DMP, that information
may be included in this section, as applicable.]
If you have questions about your opioid pain medication or other prescription drugs you are taking,
speak with your prescriber.

_______________________________________________
PRA Disclosure Statement According to the Paperwork Reduction Act of 1995, no persons are required to
respond to a collection of information unless it displays a valid OMB control number. The valid OMB control
number for this collection is 0938-0964. The time required to complete this information collection is estimated
to average 5 minutes per response, including the time to review instructions, search existing data resources,
Form CMS-10141

OMB Approval No. 0938-0964 (Expires xx/xx/xxxx)

and gather the data needed, and complete and review the information collection. If you have any comments
concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to CMS,
7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Baltimore, Maryland 21244-1850.
CMS does not discriminate in its programs and activities: To request this form in an accessible format (e.g.,
Braille, Large Print, Audio CD) contact your Medicare Drug Plan. If you need assistance contacting your plan,
call: 1-800-MEDICARE.

Form CMS-10141

OMB Approval No. 0938-0964 (Expires xx/xx/xxxx)


File Typeapplication/pdf
File TitleAlternate 2nd Notice
AuthorMDBG-DPDP
File Modified2021-10-14
File Created2021-10-14

© 2024 OMB.report | Privacy Policy